Cancer

Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation

Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory…

3 months ago

Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation

Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory…

3 months ago

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2025 financial guidance provided on 3Q25…

3 months ago

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2025 financial guidance provided on 3Q25…

3 months ago

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine…

3 months ago

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine…

3 months ago

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

AUSTIN, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: As late-stage biotech pipelines mature, fair-value remeasurements under U.S.…

3 months ago

FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers

HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued…

3 months ago

Persephone Biosciences Announces Positive Topline Results from ARTEMIS Clinical Trial of First-of-its-kind Synbiotic for Children

- 114 infants and toddlers received Persephone’s synbiotic or placebo - - The study generated important, positive clinical data on…

3 months ago

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1

Evaxion’s AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component…

3 months ago